Drug Information

Drug General Information
Drug ID
D03JFC
Former ID
DNC014111
Drug Name
3-(benzo[d]oxazol-2-yl)phenyl propylcarbamate
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530218]
Formula
C17H16N2O3
Canonical SMILES
CCCNC(=O)OC1=CC=CC(=C1)C2=NC3=CC=CC=C3O2
InChI
1S/C17H16N2O3/c1-2-10-18-17(20)21-13-7-5-6-12(11-13)16-19-14-8-3-4-9-15(14)22-16/h3-9,11H,2,10H2,1H3,(H,18,20)
InChIKey
VWTFAQPOTOAJGW-UHFFFAOYSA-N
PubChem Compound ID
44244229
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [530218]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 530218Eur J Med Chem. 2009 Oct;44(10):4179-91. Epub 2009 May 22.Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
Ref 530218Eur J Med Chem. 2009 Oct;44(10):4179-91. Epub 2009 May 22.Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.